Canopy Growth Corporation (CGC)
NASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$0.98
▲ +5.25%
Market Cap
$414.2M
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Beta
2.41
52-Wk Range
0.844-2.38
CEO
Luc Mongeau
Country
CA
Currency
USD
Canopy Growth Corporation (CGC), alongside its affiliated businesses, specializes in the cultivation, marketing, and retail of both cannabis and hemp-derived products. These offerings are designed for both recreational consumption and therapeutic uses, with its primary commercial reach extending across Canada, the United States, and Germany. The company structures its operations into two main divisions: Global Cannabis and a diverse portfolio of Other Consumer Products. Its extensive product range features dried cannabis flower, various extracts and concentrates, infused beverages, edible gumm…
Open full interactive analysis & DCF →